Arcutis to Report Second Quarter 2025 Financial Results and Host Conference Call on August 6, 2025

Company Overview - Arcutis Biotherapeutics, Inc. is a commercial-stage biopharmaceutical company focused on immuno-dermatology innovations [3] - The company has a growing portfolio of advanced targeted topicals approved for treating three major inflammatory skin diseases [3] - Arcutis aims to address urgent needs in dermatology, particularly for individuals with immune-mediated dermatological diseases [3] Upcoming Financial Results - Arcutis will report its second quarter 2025 financial results and provide a business update on August 6, 2025, after U.S. financial markets close [1] - A conference call and webcast will be held on the same day at 4:30 p.m. ET [1][2] - The webcast and presentation materials will be available on the company's website, with an archived replay accessible afterward [2]